These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20552794)

  • 21. [Antioxidant protection in surgical correction of inborn heart disease with the use of artificial circulation].
    Bakhareva IuA; Nadiradze ZZ
    Khirurgiia (Mosk); 2011; (5):61-5. PubMed ID: 21666584
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antioxidant protection as a component of anesthetic management cancer patients].
    Tumanian SV; Ivanova LG
    Khirurgiia (Mosk); 2011; (6):66-9. PubMed ID: 21716223
    [No Abstract]   [Full Text] [Related]  

  • 23. [THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS].
    Markevich PS; Markevich LB; Plekhanov AN; Kovalenko AL
    Klin Med (Mosk); 2015; 93(6):67-72. PubMed ID: 26495531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy].
    Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV
    Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
    Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM
    Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytoflavin in the treatment of patients with chronic abacterial prostatitis and erectile dysfunction].
    Churakov AA; Kolesnikov AI; Bliumberg BI; Popkov VM
    Urologiia; 2012; (5):64-6, 68. PubMed ID: 23342619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
    Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD
    Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacological treatment of hemorheological disorders in children with acute respiratory viral infection].
    Mikhaĭlova EV; Danilova AN; Chudakova TK; Romanovskaia AV; Dubovitskaia NA; Belova AE
    Eksp Klin Farmakol; 2013; 76(8):43-6. PubMed ID: 24228490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of cytoflavin into the complex intensive therapy of acute cerebral insufficiency caused by poisoning].
    Vasilyev S; Shilov V; Aleksandrov M; Batotsyrenov B; Loladze A
    Georgian Med News; 2012 Feb; (203):22-9. PubMed ID: 22466536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study cytoflavin dose-dependent effect in the treatment of acute ischemic stroke].
    Sazonov IE; Kudinov AA; Fedotova EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):64-67. PubMed ID: 28374695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Features of psychopharmacotherapeutic correction of alcohol dependence in the elderly].
    Belov VG; Parfenov IuA; Zaplutanov VA
    Adv Gerontol; 2013; 26(4):702-6. PubMed ID: 24738263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The intraoperative prophylaxis of local ischemical brain damage in neurosurgical patients with cerebral aneurysm].
    Savvina IA; Cherebillo VY; Zabrodskaya YM; Petrova AO; Sergeev AV; Paltsev AA; Rutkovskiy RV; Malkhozova AM
    Khirurgiia (Mosk); 2019; (5):57-63. PubMed ID: 31169820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental study on cytoflavin pharmacological correction of cyclophosphamide-induced toxic affections of the liver and kidneys].
    Kashuro VA; Glushkov SI; Minaeva LV; Novikova TM
    Antibiot Khimioter; 2010; 55(9-10):29-32. PubMed ID: 21400751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenetic therapy of tuberculosis of respiratory organs during sanatorium-and-spa treatment].
    Sukhanov DS; Ivanov AK; Kovalenko AL; Dziuba EG; Andreeva MN; Romantsov MG
    Vopr Kurortol Fizioter Lech Fiz Kult; 2009; (6):34-7. PubMed ID: 20017380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correction of central nervous system energy processes in children with the minimal cerebral dysfunction].
    Lavrik SIu; Domitrak SV; Shprakh VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4):37-41. PubMed ID: 21512499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytoflavine effect on exudative-destructive manifestations of lung tuberculosis in children and teenagers].
    Volchegorskiĭ IA; Novoselov PN; Denisenko IA
    Eksp Klin Farmakol; 2009; 72(4):20-4. PubMed ID: 19803365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacotherapy of basic clinical presentations of chronic brain ischemia].
    Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 1):60-2. PubMed ID: 21946144
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antioxidant therapy in discirculatory encephalopathy].
    Antipenko EA; Gustov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819
    [No Abstract]   [Full Text] [Related]  

  • 39. [Modern methods of energy homeostasis correction in elderly patients].
    Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN
    Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
    Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.